CULP Form 4: Director Alexander B. Jones Granted 22,261 RSUs
Rhea-AI Filing Summary
Alexander B. Jones, a director of Culp, Inc. (CULP), reported restricted stock unit transactions dated September 24-25, 2025. The Form 4 shows contingent rights to receive 9,197 shares tied to a September 24, 2025 grant and an additional 13,064 restricted stock units granted on September 25, 2025. The reported RSUs are described as contingent on the reporting person remaining a director through the earlier of the one-year anniversary of the grant or the next annual meeting that is at least 50 weeks after the prior meeting.
The filing records an acquisition code and zero per-share price, indicating issuance of RSUs rather than a cash purchase. The report also notes the reporting person may be part of a Section 13(d) group owning more than 10% of the issuer and disclaims beneficial ownership of securities held by other group members.
Positive
- Director received equity compensation totaling 22,261 restricted stock units, aligning interests with shareholders
- RSUs are service-based and contingent, which ties value to continued board service
Negative
- Reporting person may be part of a Section 13(d) group owning >10%, which could complicate ownership disclosures
- RSUs are contingent and not immediately vested or issued, so no immediate share issuance is guaranteed
Insights
TL;DR: Routine director equity grants tied to continued service; governance note about potential Section 13(d) group membership.
The transaction reflects standard director compensation via restricted stock units that vest based on continued board service or timing of the annual meeting. Such grants align director incentives with shareholder value without immediate dilution because they are contingent and reported as RSUs with a $0 exercise price until issuance. The disclosure that the reporting person "may be deemed" part of a Section 13(d) group is a governance footnote that could affect disclosure obligations but does not, by itself, quantify additional holdings.
TL;DR: Insider acquired contingent rights to 22,261 shares; transaction appears administrative and non-cash.
The Form 4 documents acquisition of a total of 22,261 restricted stock units (9,197 and 13,064) granted on consecutive dates and reported under transaction codes consistent with issuance of equity awards. The reported price of $0 indicates these are service-based RSUs rather than market purchases. The post-transaction beneficial ownership figures are disclosed for the affected classes; no derivatives exercisable immediately or cash consideration are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 13,064 | $0.00 | -- |
| Exercise | Restricted Stock Units | 9,197 | $0.00 | -- |
| Exercise | Common Stock | 9,197 | $0.00 | -- |
Footnotes (1)
- Contingent right to receive issuance of Culp, Inc. common stock. The reporting person may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding common stock. The reporting person disclaims beneficial ownership of the securities owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. These restricted stock units represent the right to receive 9,197 shares of Culp, Inc. common stock based on the reporting person remaining a director as of the date that is the earlier of (i) the one-year anniversary of the date of the grant, or (ii) the next annual meeting of shareholders of the Issuer which is at least 50 weeks after the immediately preceding year's annual meeting. The reporting person holds no more restricted stock units with a vesting date of the Issuer's September 24, 2025, annual meeting of shareholders. These restricted stock units represent the right to receive 13,064 shares of Culp, Inc. common stock based on the reporting person remaining a director as of the date that is the earlier of (i) the one-year anniversary of the date of the grant, or (ii) the next annual meeting of shareholders of the Issuer which is at least 50 weeks after the Issuer's September 24, 2025, annual meeting of shareholders.
